{
    "code": "01038233",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01038233",
    "time": "2019-10-18 03:27:39",
    "許可證字號": "衛署藥製字第038233號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/11\/02",
    "發證日期": "83\/11\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103823305",
    "中文品名": "達康胃懸液２０公絲\/公撮（希每得定）",
    "英文品名": "DA CON WEI SUSPENSION 20MG\/ML (CIMETIDINE) &quot;C.M.&quot;",
    "適應症": "胃潰瘍、十二指腸潰瘍、消化性食道炎、上胃腸道糜爛或潰瘍引起之出血、再發性潰瘍、穿孔性潰瘍、Ｚｏｌｌｉｎｇｅｒ－Ｅｌｌｉｓｏｎ症侯群，及其他胃酸分泌過高之症狀、及膽囊纖維變性併發有胰臟功能不全時之補助療法。",
    "劑型": "183懸液劑",
    "包裝": "鋁箔裝 盒裝 塑膠容器裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": "CIMETIDINE",
    "主製造廠": {
        "申請商名稱": "0402211200  中美兄弟製藥股份有限公司",
        "申請商地址": "彰化市東芳里彰鹿路１０６號",
        "主製造廠": "",
        "製造廠名稱": "0402211300  中美兄弟製藥股份有限公司"
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640000500",
            "成分名稱": "CIMETIDINE",
            "含量描述": "20",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "0116-達康胃懸液-說-104-12-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038233&Seq=001&Type=9"
        },
        {
            "title": "0116-達康胃懸液-盒-104-12-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01038233&Seq=001&Type=8"
        }
    ]
}